The all-virtual ACR Convergence 2020 experience includes the highest-quality educational content along with innovative session formats and multiple opportunities to network with colleagues. We invite you to explore The Rheumatologist’s complete coverage of the meeting. Plus, explore our resource centers focused on rheumatoid arthritis, systemic lupus erythematosus and gout, along with our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of these conditions.

Resource Centers
Systemic Lupus Erythematosus Resource Center
Watch this space for our coverage of systemic lupus erythematosus (SLE) sessions at ACR Convergence 2020, including the top research presented at the meeting. Plus, explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of SLE.
VIEWRheumatoid Arthritis Resource Center
The Great Debate at ACR Convergence 2020 was: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After Methotrexate Failure in RA. No need to hang in suspense. In this resource center, you’ll get the pros and cons of JAK inhibitors, our expert’s picks for the top research presented and highlights from other important sessions on rheumatoid arthritis (RA). Plus, you can explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of RA.
VIEWGout Resource Center
Earlier this year, the ACR released a new guideline for the management of gout, leaving some rheumatologists unsure what to recommend to their patients. Clearing up the confusion is one aim of the session, Evidence-Based Guidance for Optimizing Gout Management. Learn what the experts recommend and explore our coverage of the top research and additional gout information presented at ACR Convergence 2020, plus our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of gout.
VIEW
- 1
- 2
- 3
- …
- 10
- Next Page »